Comparison of the effect of local administration of bupivacaine and dexamethasone combination with bupivacaine administration only in postoperative pain in patients undergoing thoracotomy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220309054226N1

Enrollment

Registered

2022-03-21

Start date

2022-03-21

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute post-thoracotomy pain. Acute post-thoracotomy pain

Interventions

Intervention 1: Intervention group: Local injection of 2.5 milligram bupivacaine (AuroMedics Pharma LLC, USA) and 0.2 milligram dexamethasone (Caspian Tamin, IRAN) per kilogram of body weight in the s

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are candidate for thoracotomy Consent to participate in the study

Exclusion criteria

Exclusion criteria: History of allergy to the used medications

Design outcomes

Primary

Measure	Time frame
Acute post-thoracotomy pain. Timepoint: 6, 12 and 24 hours after surgery. Method of measurement: Visual Analog Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPouriya Sarboloukzadeh Harandi

Esfahan University of Medical Sciences

Dr.pooriasharandi@yahoo.com+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026